Integrative Genomics Reveals Novel Molecular Pathways and Gene Networks for Coronary Artery Disease
Sudden death due to heart attack ranks among the top causes of death in the world, and family studies have shown that genetics has a substantial effect on heart disease risk. Recent studies suggest that multiple genetic factors each with modest effects are necessary for the development of CAD, but the genes and molecular processes involved remain poorly understood. We conducted an integrative genomics study where we used the information of gene-gene interactions to capture groups of genes that are most likely to increase heart disease risk. We not only confirmed the importance of several known CAD risk processes such as the metabolism and transport of cholesterol, immune response, and blood coagulation, but also revealed many novel processes such as neuroprotection, cell cycle, and proteolysis that were not previously implicated in CAD. In particular, we highlight several genes such as GLO1 with key regulatory roles within these processes not detected by the first wave of genetic analyses. These results highlight the value of integrating population genetic data with diverse resources that functionally annotate the human genome. Such integration facilitates the identification of novel molecular processes involved in the pathogenesis of CAD as well as potential novel targets for the development of efficacious therapeutic interventions.
Vyšlo v časopise:
Integrative Genomics Reveals Novel Molecular Pathways and Gene Networks for Coronary Artery Disease. PLoS Genet 10(7): e32767. doi:10.1371/journal.pgen.1004502
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1004502
Souhrn
Sudden death due to heart attack ranks among the top causes of death in the world, and family studies have shown that genetics has a substantial effect on heart disease risk. Recent studies suggest that multiple genetic factors each with modest effects are necessary for the development of CAD, but the genes and molecular processes involved remain poorly understood. We conducted an integrative genomics study where we used the information of gene-gene interactions to capture groups of genes that are most likely to increase heart disease risk. We not only confirmed the importance of several known CAD risk processes such as the metabolism and transport of cholesterol, immune response, and blood coagulation, but also revealed many novel processes such as neuroprotection, cell cycle, and proteolysis that were not previously implicated in CAD. In particular, we highlight several genes such as GLO1 with key regulatory roles within these processes not detected by the first wave of genetic analyses. These results highlight the value of integrating population genetic data with diverse resources that functionally annotate the human genome. Such integration facilitates the identification of novel molecular processes involved in the pathogenesis of CAD as well as potential novel targets for the development of efficacious therapeutic interventions.
Zdroje
1. FischerM, BroeckelU, HolmerS, BaesslerA, HengstenbergC, et al. (2005) Distinct heritable patterns of angiographic coronary artery disease in families with myocardial infarction. Circulation 111: 855–862.
2. ZdravkovicS, WienkeA, PedersenNL, MarenbergME, YashinAI, et al. (2002) Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med 252: 247–254.
3. DeloukasP, KanoniS, WillenborgC, FarrallM, AssimesTL, et al. (2013) Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet 45: 25–33.
4. SchunkertH, KonigIR, KathiresanS, ReillyMP, AssimesTL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333–338.
5. GaffneyDJ (2013) Global properties and functional complexity of human gene regulatory variation. PLoS Genet 9: e1003501.
6. LeeTI, YoungRA (2013) Transcriptional regulation and its misregulation in disease. Cell 152: 1237–1251.
7. SchadtEE, LambJ, YangX, ZhuJ, EdwardsS, et al. (2005) An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 37: 710–717.
8. SchadtEE, MolonyC, ChudinE, HaoK, YangX, et al. (2008) Mapping the genetic architecture of gene expression in human liver. PLoS Biol 6: e107.
9. YangX (2012) Use of functional genomics to identify candidate genes underlying human genetic association studies of vascular diseases. Arterioscler Thromb Vasc Biol 32: 216–222.
10. ChenY, ZhuJ, LumPY, YangX, PintoS, et al. (2008) Variations in DNA elucidate molecular networks that cause disease. Nature 452: 429–435.
11. EmilssonV, ThorleifssonG, ZhangB, LeonardsonAS, ZinkF, et al. (2008) Genetics of gene expression and its effect on disease. Nature 452: 423–428.
12. WangIM, ZhangB, YangX, ZhuJ, StepaniantsS, et al. (2012) Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers. Mol Syst Biol 8: 594.
13. ZhangB, HorvathS (2005) A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 4: Article17.
14. DixonAL, LiangL, MoffattMF, ChenW, HeathS, et al. (2007) A genome-wide association study of global gene expression. Nat Genet 39: 1202–1207.
15. FehrmannRS, JansenRC, VeldinkJH, WestraHJ, ArendsD, et al. (2011) Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet 7: e1002197.
16. GreenawaltDM, DobrinR, ChudinE, HatoumIJ, SuverC, et al. (2011) A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. Genome Res 21: 1008–1016.
17. DaviesRW, WellsGA, StewartAF, ErdmannJ, ShahSH, et al. (2012) A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ Cardiovasc Genet 5: 217–225.
18. VastrikI, D'EustachioP, SchmidtE, GopinathG, CroftD, et al. (2007) Reactome: a knowledge base of biologic pathways and processes. Genome Biol 8: R39.
19. OgataH, GotoS, SatoK, FujibuchiW, BonoH, et al. (1999) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 27: 29–34.
20. HindorffLA, SethupathyP, JunkinsHA, RamosEM, MehtaJP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362–9367.
21. LiuH, LiuW, LiaoY, ChengL, LiuQ, et al. (2011) CADgene: a comprehensive database for coronary artery disease genes. Nucleic Acids Res 39: D991–996.
22. ZhangK, CuiS, ChangS, ZhangL, WangJ (2010) i-GSEA4GWAS: a web server for identification of pathways/gene sets associated with traits by applying an improved gene set enrichment analysis to genome-wide association study. Nucleic Acids Res 38: W90–95.
23. SegreAV, GroopL, MoothaVK, DalyMJ, AltshulerD (2010) Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet 6: e1001058.
24. NamD, KimJ, KimSY, KimS (2010) GSA-SNP: a general approach for gene set analysis of polymorphisms. Nucleic Acids Res 38: W749–754.
25. LappalainenT, SammethM, FriedlanderMR, t HoenPA, MonlongJ, et al. (2013) Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501: 506–511.
26. BattleA, MostafaviS, ZhuX, PotashJB, WeissmanMM, et al. (2014) Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res 24: 14–24.
27. WestraHJ, PetersMJ, EskoT, YaghootkarH, SchurmannC, et al. (2013) Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 45: 1238–1243.
28. YangX, ZhangB, MolonyC, ChudinE, HaoK, et al. (2010) Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res 20: 1020–1036.
29. ZhuJ, ZhangB, SmithEN, DreesB, BremRB, et al. (2008) Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks. Nat Genet 40: 854–861.
30. GohKI, CusickME, ValleD, ChildsB, VidalM, et al. (2007) The human disease network. Proc Natl Acad Sci U S A 104: 8685–8690.
31. DavignonJ, GanzP (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109: III27–32.
32. RomanoskiCE, LeeS, KimMJ, Ingram-DrakeL, PlaisierCL, et al. (2010) Systems genetics analysis of gene-by-environment interactions in human cells. Am J Hum Genet 86: 399–410.
33. WangK, ZhangH, KugathasanS, AnneseV, BradfieldJP, et al. (2009) Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am J Hum Genet 84: 399–405.
34. de las FuentesL, YangW, Davila-RomanVG, GuC (2012) Pathway-based genome-wide association analysis of coronary heart disease identifies biologically important gene sets. Eur J Hum Genet 20: 1168–1173.
35. KangHP, YangX, ChenR, ZhangB, CoronaE, et al. (2012) Integration of disease-specific single nucleotide polymorphisms, expression quantitative trait loci and coexpression networks reveal novel candidate genes for type 2 diabetes. Diabetologia 55: 2205–2213.
36. ZhongH, BeaulaurierJ, LumPY, MolonyC, YangX, et al. (2010) Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet 6: e1000932.
37. ZhongH, YangX, KaplanLM, MolonyC, SchadtEE (2010) Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am J Hum Genet 86: 581–591.
38. DuanS, LuoX, DongC (2013) Identification of susceptibility modules for coronary artery disease using a genome wide integrated network analysis. Gene 531: 347–354.
39. HuanT, ZhangB, WangZ, JoehanesR, ZhuJ, et al. (2013) A systems biology framework identifies molecular underpinnings of coronary heart disease. Arterioscler Thromb Vasc Biol 33: 1427–1434.
40. LiH, ZuoX, OuyangP, LinM, ZhaoZ, et al. (2014) Identifying functional modules for coronary artery disease by a prior knowledge-based approach. Gene 537: 260–268.
41. ZhangB, GaiteriC, BodeaLG, WangZ, McElweeJ, et al. (2013) Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153: 707–720.
42. BarterP (2009) Lessons learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. Am J Cardiol 104: 10E–15E.
43. BarterPJ, RyeKA, TardifJC, WatersDD, BoekholdtSM, et al. (2011) Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. Circulation 124: 555–562.
44. WensleyF, GaoP, BurgessS, KaptogeS, Di AngelantonioE, et al. (2011) Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ 342: d548.
45. RabbaniN, ThornalleyPJ (2011) Glyoxalase in diabetes, obesity and related disorders. Semin Cell Dev Biol 22: 309–317.
46. Perez-VictoriaFJ, MardonesGA, BonifacinoJS (2008) Requirement of the human GARP complex for mannose 6-phosphate-receptor-dependent sorting of cathepsin D to lysosomes. Mol Biol Cell 19: 2350–2362.
47. PersichettiE, ChuzhanovaNA, DardisA, TappinoB, PohlS, et al. (2009) Identification and molecular characterization of six novel mutations in the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTG) gene in patients with mucolipidosis III gamma. Hum Mutat 30: 978–984.
48. FerreiraPA, OrryA (2012) From Drosophila to humans: reflections on the roles of the prolyl isomerases and chaperones, cyclophilins, in cell function and disease. J Neurogenet 26: 132–143.
49. HuaT, WuD, DingW, WangJ, ShawN, et al. (2012) Studies of human 2,4-dienoyl CoA reductase shed new light on peroxisomal beta-oxidation of unsaturated fatty acids. J Biol Chem 287: 28956–28965.
50. BornfeldtKE, TabasI (2011) Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab 14: 575–585.
51. SchiffrinEL, LipmanML, MannJF (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation 116: 85–97.
52. GiaccoF, DuX, D'AgatiVD, MilneR, SuiG, et al. (2013) Knockdown of Glo1 mimics diabetic nephropathy in non-diabetic mice. Diabetes 63: 291–299.
53. MiyataT, van Ypersele de StrihouC, ImasawaT, YoshinoA, UedaY, et al. (2001) Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient. Kidney Int 60: 2351–2359.
54. VulesevicB, McNeillB, GeoffrionM, KuraitisD, McBaneJE, et al. (2013) Glyoxalase-1 over-expression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice. Cardiovasc Res 101: 306–316.
55. LangF, BohmerC, PalmadaM, SeebohmG, Strutz-SeebohmN, et al. (2006) (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 86: 1151–1178.
56. EtoN, MiyagishiM, InagiR, FujitaT, NangakuM (2009) Mitogen-activated protein 3 kinase 6 mediates angiogenic and tumorigenic effects via vascular endothelial growth factor expression. Am J Pathol 174: 1553–1563.
57. ShuaiY, GuoJ, DongY, ZhongW, XiaoP, et al. (2011) Global gene expression profiles of MT knockout and wild-type mice in the condition of doxorubicin-induced cardiomyopathy. Toxicol Lett 200: 77–87.
58. JaitovichA, BertorelloAM (2010) Intracellular sodium sensing: SIK1 network, hormone action and high blood pressure. Biochim Biophys Acta 1802: 1140–1149.
59. CongrainsA, KamideK, OguroR, YasudaO, MiyataK, et al. (2012) Genetic variants at the 9p21 locus contribute to atherosclerosis through modulation of ANRIL and CDKN2A/B. Atherosclerosis 220: 449–455.
60. BoyleAP, HongEL, HariharanM, ChengY, SchaubMA, et al. (2012) Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 22: 1790–1797.
61. DjebaliS, DavisCA, MerkelA, DobinA, LassmannT, et al. (2012) Landscape of transcription in human cells. Nature 489: 101–108.
62. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45: 580–585.
63. PreussM, KonigIR, ThompsonJR, ErdmannJ, AbsherD, et al. (2010) Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet 3: 475–483.
64. PriceAL, PattersonNJ, PlengeRM, WeinblattME, ShadickNA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904–909.
65. SchaubMA, BoyleAP, KundajeA, BatzoglouS, SnyderM (2012) Linking disease associations with regulatory information in the human genome. Genome Res 22: 1748–1759.
66. The International HapMap Project. Nature 426: 789–796.
67. ZhuJ, WienerMC, ZhangC, FridmanA, MinchE, et al. (2007) Increasing the power to detect causal associations by combining genotypic and expression data in segregating populations. PLoS Comput Biol 3: e69.
68. Pearl J (1988) Probabilistic reasoning in intelligent systems: networks of plausible inference. San Mateo, Calif.: Morgan Kaufmann Publishers. xix: , 552 p.
69. MadiganDaYJ (1995) Bayesian graphical models for discrete data. International Statistical Review 63: 215–232.
70. ZhuJ, LumPY, LambJ, GuhaThakurtaD, EdwardsSW, et al. (2004) An integrative genomics approach to the reconstruction of gene networks in segregating populations. Cytogenet Genome Res 105: 363–374.
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2014 Číslo 7
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Wnt Signaling Interacts with Bmp and Edn1 to Regulate Dorsal-Ventral Patterning and Growth of the Craniofacial Skeleton
- Novel Approach Identifies SNPs in and with Evidence for Parent-of-Origin Effect on Body Mass Index
- Hypoxia Adaptations in the Grey Wolf () from Qinghai-Tibet Plateau
- DNA Topoisomerase 1α Promotes Transcriptional Silencing of Transposable Elements through DNA Methylation and Histone Lysine 9 Dimethylation in